Akums Drugs & Pharmaceuticals Ltd.
•₹ 750-0.39%
2026-08-21
PROS
- Company is almost debt free
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 3.14x)
- Company has been maintaining a healthy dividend payout of 41.1%
- Company comfortably covers its interest (15.8x coverage)
- Institutional investors have been accumulating - FII+DII up 2.3pp
CONS
- A large part of profit comes from other income (76.1% of PBT)
- Recent results are weak - TTM profit is down 58.2% versus prior year
- Company has a low return on equity of -18.3% over last 3 years
- Operating cash flow has been negative in recent years
- Company has a low return on capital employed of 1.0%
- Promoter holding has decreased over last 2 years: -9.6pp
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1901.00 | 37.71 | 456113.58 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8587.00 | 77.93 | 227957.87 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 4994.90 | 87.11 | 189989.94 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1437.65 | 34.46 | 116141.01 | 0.90 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1108.80 | 24.51 | 110603.22 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2203.10 | 18.22 | 100733.42 | 0.82 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | DRREDDY | 1181.35 | 30.60 | 98604.43 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 8. | MANKIND | 2385.00 | 48.22 | 98499.54 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 9. | LAURUSLABS | 1823.00 | 90.09 | 98498.92 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1606.40 | 24.90 | 92428.71 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 412.10 | 135.59 | 67159.70 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | AKUMS | 753.20 | 40.64 | 11854.92 | 0.40 | 100.98 | 56.11 | 1166.63 | 13.93 | 14.77 | 14.97 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 316 | 447 | 383 | 298 | 317 | 328 | 337 | 329 | 332 | 309 | 369 | 338 | 392 | |
| 503 | 358 | 351 | 359 | 274 | 285 | 303 | 311 | 288 | 292 | 344 | 327 | 359 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 20 | 22 | 25 | 27 | 26 | 32 | 34 | 32 | 29 | 27 | 30 | 28 | 26 |
| Interest | 4 | 5 | 5 | 5 | 6 | 4 | 2 | 3 | 3 | 2 | 2 | 3 | 2 |
| Depreciation | 7 | 8 | 8 | 9 | 9 | 9 | 11 | 10 | 10 | 11 | 12 | 12 | 13 |
| -178 | 81 | 43 | -49 | 54 | 62 | 55 | 37 | 60 | 31 | 36 | 22 | 59 | |
| Tax % | -6.36% | 34.85% | 32.47% | -18.01% | 22.85% | 18.26% | 25.00% | 25.55% | 24.60% | 24.81% | 21.61% | 30.24% | 24.43% |
| Net Profit | -190 | 53 | 29 | -58 | 42 | 50 | 41 | 28 | 45 | 23 | 28 | 15 | 45 |
| -13 | 4 | 2 | -4 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 1 | 0 | |
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 29 | 29 | 29 | 29 | 29 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 316
- 503
- Operating Profit
- —
- OPM %
- —
- Other Income
- 20
- Interest
- 4
- Depreciation
- 7
- -178
- Tax %
- -6.36%
- Net Profit
- -190
- -13
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 447
- 358
- Operating Profit
- —
- OPM %
- —
- Other Income
- 22
- Interest
- 5
- Depreciation
- 8
- 81
- Tax %
- 34.85%
- Net Profit
- 53
- 4
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 383
- 351
- Operating Profit
- —
- OPM %
- —
- Other Income
- 25
- Interest
- 5
- Depreciation
- 8
- 43
- Tax %
- 32.47%
- Net Profit
- 29
- 2
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 298
- 359
- Operating Profit
- —
- OPM %
- —
- Other Income
- 27
- Interest
- 5
- Depreciation
- 9
- -49
- Tax %
- -18.01%
- Net Profit
- -58
- -4
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 317
- 274
- Operating Profit
- —
- OPM %
- —
- Other Income
- 26
- Interest
- 6
- Depreciation
- 9
- 54
- Tax %
- 22.85%
- Net Profit
- 42
- 3
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 29
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 328
- 285
- Operating Profit
- —
- OPM %
- —
- Other Income
- 32
- Interest
- 4
- Depreciation
- 9
- 62
- Tax %
- 18.26%
- Net Profit
- 50
- 3
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 337
- 303
- Operating Profit
- —
- OPM %
- —
- Other Income
- 34
- Interest
- 2
- Depreciation
- 11
- 55
- Tax %
- 25.00%
- Net Profit
- 41
- 3
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 329
- 311
- Operating Profit
- —
- OPM %
- —
- Other Income
- 32
- Interest
- 3
- Depreciation
- 10
- 37
- Tax %
- 25.55%
- Net Profit
- 28
- 2
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 332
- 288
- Operating Profit
- —
- OPM %
- —
- Other Income
- 29
- Interest
- 3
- Depreciation
- 10
- 60
- Tax %
- 24.60%
- Net Profit
- 45
- 3
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 309
- 292
- Operating Profit
- —
- OPM %
- —
- Other Income
- 27
- Interest
- 2
- Depreciation
- 11
- 31
- Tax %
- 24.81%
- Net Profit
- 23
- 2
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 369
- 344
- Operating Profit
- —
- OPM %
- —
- Other Income
- 30
- Interest
- 2
- Depreciation
- 12
- 36
- Tax %
- 21.61%
- Net Profit
- 28
- 2
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 338
- 327
- Operating Profit
- —
- OPM %
- —
- Other Income
- 28
- Interest
- 3
- Depreciation
- 12
- 22
- Tax %
- 30.24%
- Net Profit
- 15
- 1
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 392
- 359
- Operating Profit
- —
- OPM %
- —
- Other Income
- 26
- Interest
- 2
- Depreciation
- 13
- 59
- Tax %
- 24.43%
- Net Profit
- 45
- 0
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 31
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 628 | 596 | 683 | 737 | 837 | 1,162 | 1,287 | 1,444 | 1,312 | 1,349 | 1,409 | |
| 599 | 521 | 601 | 697 | 811 | 1,524 | 1,089 | 1,571 | 1,177 | 1,251 | 1,322 | |
| Operating Profit | 72 | 131 | 139 | 105 | 81 | -304 | 338 | -33 | 263 | 210 | — |
| OPM % | 12 | 22 | 20 | 14 | 10 | -26 | 26 | -2 | 20 | 16 | — |
| Other Income | 43 | 55 | 57 | 66 | 55 | 58 | 140 | 94 | 128 | 113 | 111 |
| Interest | 5 | 3 | 4 | 4 | 1 | 4 | 13 | 18 | 15 | 10 | 10 |
| Depreciation | 24 | 23 | 23 | 25 | 26 | 28 | 30 | 33 | 40 | 46 | 48 |
| 43 | 105 | 112 | 76 | -195 | -335 | 150 | -103 | 208 | 148 | 148 | |
| Tax % | 25 | 35 | 33 | 33 | 25 | -14 | 17 | -61 | 23 | 25 | 25 |
| Net Profit | 32 | 68 | 75 | 51 | -145 | -382 | 125 | -165 | 161 | 112 | 112 |
| EPS | 276 | 580 | 636 | 391 | -20 | -27 | 9 | -12 | 11 | 7 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 5 | 6 | 4 | -10 | -27 | 9 | -12 | 11 | 7 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 5 | 6 | 4 | -10 | -27 | 9 | -12 | 11 | 7 | — |
Mar 2017
- 628
- 599
- Operating Profit
- 72
- OPM %
- 12
- Other Income
- 43
- Interest
- 5
- Depreciation
- 24
- 43
- Tax %
- 25
- Net Profit
- 32
- EPS
- 276
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2018
- 596
- 521
- Operating Profit
- 131
- OPM %
- 22
- Other Income
- 55
- Interest
- 3
- Depreciation
- 23
- 105
- Tax %
- 35
- Net Profit
- 68
- EPS
- 580
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2019
- 683
- 601
- Operating Profit
- 139
- OPM %
- 20
- Other Income
- 57
- Interest
- 4
- Depreciation
- 23
- 112
- Tax %
- 33
- Net Profit
- 75
- EPS
- 636
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2020
- 737
- 697
- Operating Profit
- 105
- OPM %
- 14
- Other Income
- 66
- Interest
- 4
- Depreciation
- 25
- 76
- Tax %
- 33
- Net Profit
- 51
- EPS
- 391
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2021
- 837
- 811
- Operating Profit
- 81
- OPM %
- 10
- Other Income
- 55
- Interest
- 1
- Depreciation
- 26
- -195
- Tax %
- 25
- Net Profit
- -145
- EPS
- -20
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -10
Mar 2022
- 1,162
- 1,524
- Operating Profit
- -304
- OPM %
- -26
- Other Income
- 58
- Interest
- 4
- Depreciation
- 28
- -335
- Tax %
- -14
- Net Profit
- -382
- EPS
- -27
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -27
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -27
Mar 2023
- 1,287
- 1,089
- Operating Profit
- 338
- OPM %
- 26
- Other Income
- 140
- Interest
- 13
- Depreciation
- 30
- 150
- Tax %
- 17
- Net Profit
- 125
- EPS
- 9
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2024
- 1,444
- 1,571
- Operating Profit
- -33
- OPM %
- -2
- Other Income
- 94
- Interest
- 18
- Depreciation
- 33
- -103
- Tax %
- -61
- Net Profit
- -165
- EPS
- -12
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -12
Mar 2025
- 1,312
- 1,177
- Operating Profit
- 263
- OPM %
- 20
- Other Income
- 128
- Interest
- 15
- Depreciation
- 40
- 208
- Tax %
- 23
- Net Profit
- 161
- EPS
- 11
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 11
Mar 2026
- 1,349
- 1,251
- Operating Profit
- 210
- OPM %
- 16
- Other Income
- 113
- Interest
- 10
- Depreciation
- 46
- 148
- Tax %
- 25
- Net Profit
- 112
- EPS
- 7
- Dividend Payout %
- 41
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
TTM
- 1,409
- 1,322
- Operating Profit
- —
- OPM %
- —
- Other Income
- 111
- Interest
- 10
- Depreciation
- 48
- 148
- Tax %
- 25
- Net Profit
- 112
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 9%
- 5 Years:
- 10%
- 3 Years:
- 2%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 10%
- 5 Years:
- —
- 3 Years:
- -4%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- 56%
RETURN ON EQUITY
- 10 Years:
- -10%
- 5 Years:
- -21%
- 3 Years:
- -18%
- Last Year:
- 5%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 1 | 1 | 1 | 1 | 1 | 14 | 29 | 29 | 31 | 31 |
| 698 | 766 | 841 | 711 | 566 | 171 | 283 | 115 | 2,275 | 2,397 | |
| 47 | 33 | 51 | 36 | 23 | 122 | 124 | 204 | 4 | 14 | |
| Trade Payables | 43 | 86 | 69 | 108 | 90 | 252 | 178 | 165 | 220 | 201 |
| 71 | 74 | 85 | 570 | 585 | 1,254 | 1,278 | 1,582 | 156 | 170 | |
| Total Liabilities | 860 | 960 | 1,046 | 1,426 | 1,265 | 1,814 | 1,891 | 2,095 | 2,685 | 2,812 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 227 | 219 | 220 | 226 | 229 | 233 | 253 | 298 | 338 | 407 | |
| Capital Work in Progress | 0 | 0 | 0 | 1 | 1 | 1 | 16 | 9 | 54 | 52 |
| 4 | 4 | 4 | 65 | 149 | 141 | 139 | 139 | 366 | 366 | |
| 88 | 121 | 106 | 123 | 96 | 179 | 197 | 162 | 202 | 230 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 234 | 206 | 218 | |
| Cash & Bank | 3 | 0 | 4 | 72 | 1 | 26 | 9 | 73 | 356 | 771 |
| 538 | 615 | 712 | 938 | 788 | 1,234 | 1,277 | 1,181 | 1,164 | 770 | |
| Total Assets | 860 | 960 | 1,046 | 1,426 | 1,265 | 1,814 | 1,891 | 2,095 | 2,685 | 2,812 |
| Total Debt | 59 | 33 | 51 | 36 | 23 | 122 | 146 | 226 | 4 | 14 |
| Net Working Capital | 125 | 145 | 146 | 316 | 225 | 19 | 25 | 31 | 524 | 1,020 |
| Contingent Liabilities | 32 | 37 | 32 | 20 | 32 | 35 | 188 | 100 | 4 | 4 |
| Book Value per Share | 5948.60 | 6528.44 | 7164.46 | 5476.91 | 4358.55 | 25.94 | 21.77 | 10.06 | 150.57 | 158.56 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Total Debt | 59 | 33 | 51 | 36 | 23 | 122 | 146 | 226 | 4 | 14 |
| Net Working Capital | 125 | 145 | 146 | 316 | 225 | 19 | 25 | 31 | 524 | 1,020 |
| Contingent Liabilities | 32 | 37 | 32 | 20 | 32 | 35 | 188 | 100 | 4 | 4 |
| Book Value per Share | 5948.60 | 6528.44 | 7164.46 | 5476.91 | 4358.55 | 25.94 | 21.77 | 10.06 | 150.57 | 158.56 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Mar 2017
- Equity Capital
- 1
- 698
- 47
- Trade Payables
- 43
- 71
- Total Liabilities
- 860
- 227
- Capital Work in Progress
- 0
- 4
- 88
- 0
- Cash & Bank
- 3
- 538
- Total Assets
- 860
- Total Debt
- 59
- Net Working Capital
- 125
- Contingent Liabilities
- 32
- Book Value per Share
- 5948.60
- Face Value
- 10.00
- Total Debt
- 59
- Net Working Capital
- 125
- Contingent Liabilities
- 32
- Book Value per Share
- 5948.60
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 1
- 766
- 33
- Trade Payables
- 86
- 74
- Total Liabilities
- 960
- 219
- Capital Work in Progress
- 0
- 4
- 121
- 0
- Cash & Bank
- 0
- 615
- Total Assets
- 960
- Total Debt
- 33
- Net Working Capital
- 145
- Contingent Liabilities
- 37
- Book Value per Share
- 6528.44
- Face Value
- 10.00
- Total Debt
- 33
- Net Working Capital
- 145
- Contingent Liabilities
- 37
- Book Value per Share
- 6528.44
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 1
- 841
- 51
- Trade Payables
- 69
- 85
- Total Liabilities
- 1,046
- 220
- Capital Work in Progress
- 0
- 4
- 106
- 0
- Cash & Bank
- 4
- 712
- Total Assets
- 1,046
- Total Debt
- 51
- Net Working Capital
- 146
- Contingent Liabilities
- 32
- Book Value per Share
- 7164.46
- Face Value
- 10.00
- Total Debt
- 51
- Net Working Capital
- 146
- Contingent Liabilities
- 32
- Book Value per Share
- 7164.46
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 1
- 711
- 36
- Trade Payables
- 108
- 570
- Total Liabilities
- 1,426
- 226
- Capital Work in Progress
- 1
- 65
- 123
- 0
- Cash & Bank
- 72
- 938
- Total Assets
- 1,426
- Total Debt
- 36
- Net Working Capital
- 316
- Contingent Liabilities
- 20
- Book Value per Share
- 5476.91
- Face Value
- 10.00
- Total Debt
- 36
- Net Working Capital
- 316
- Contingent Liabilities
- 20
- Book Value per Share
- 5476.91
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 1
- 566
- 23
- Trade Payables
- 90
- 585
- Total Liabilities
- 1,265
- 229
- Capital Work in Progress
- 1
- 149
- 96
- 0
- Cash & Bank
- 1
- 788
- Total Assets
- 1,265
- Total Debt
- 23
- Net Working Capital
- 225
- Contingent Liabilities
- 32
- Book Value per Share
- 4358.55
- Face Value
- 10.00
- Total Debt
- 23
- Net Working Capital
- 225
- Contingent Liabilities
- 32
- Book Value per Share
- 4358.55
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 14
- 171
- 122
- Trade Payables
- 252
- 1,254
- Total Liabilities
- 1,814
- 233
- Capital Work in Progress
- 1
- 141
- 179
- 0
- Cash & Bank
- 26
- 1,234
- Total Assets
- 1,814
- Total Debt
- 122
- Net Working Capital
- 19
- Contingent Liabilities
- 35
- Book Value per Share
- 25.94
- Face Value
- 2.00
- Total Debt
- 122
- Net Working Capital
- 19
- Contingent Liabilities
- 35
- Book Value per Share
- 25.94
- Face Value
- 2.00
Mar 2023
- Equity Capital
- 29
- 283
- 124
- Trade Payables
- 178
- 1,278
- Total Liabilities
- 1,891
- 253
- Capital Work in Progress
- 16
- 139
- 197
- 0
- Cash & Bank
- 9
- 1,277
- Total Assets
- 1,891
- Total Debt
- 146
- Net Working Capital
- 25
- Contingent Liabilities
- 188
- Book Value per Share
- 21.77
- Face Value
- 2.00
- Total Debt
- 146
- Net Working Capital
- 25
- Contingent Liabilities
- 188
- Book Value per Share
- 21.77
- Face Value
- 2.00
Mar 2024
- Equity Capital
- 29
- 115
- 204
- Trade Payables
- 165
- 1,582
- Total Liabilities
- 2,095
- 298
- Capital Work in Progress
- 9
- 139
- 162
- 234
- Cash & Bank
- 73
- 1,181
- Total Assets
- 2,095
- Total Debt
- 226
- Net Working Capital
- 31
- Contingent Liabilities
- 100
- Book Value per Share
- 10.06
- Face Value
- 2.00
- Total Debt
- 226
- Net Working Capital
- 31
- Contingent Liabilities
- 100
- Book Value per Share
- 10.06
- Face Value
- 2.00
Mar 2025
- Equity Capital
- 31
- 2,275
- 4
- Trade Payables
- 220
- 156
- Total Liabilities
- 2,685
- 338
- Capital Work in Progress
- 54
- 366
- 202
- 206
- Cash & Bank
- 356
- 1,164
- Total Assets
- 2,685
- Total Debt
- 4
- Net Working Capital
- 524
- Contingent Liabilities
- 4
- Book Value per Share
- 150.57
- Face Value
- 2.00
- Total Debt
- 4
- Net Working Capital
- 524
- Contingent Liabilities
- 4
- Book Value per Share
- 150.57
- Face Value
- 2.00
Mar 2026
- Equity Capital
- 31
- 2,397
- 14
- Trade Payables
- 201
- 170
- Total Liabilities
- 2,812
- 407
- Capital Work in Progress
- 52
- 366
- 230
- 218
- Cash & Bank
- 771
- 770
- Total Assets
- 2,812
- Total Debt
- 14
- Net Working Capital
- 1,020
- Contingent Liabilities
- 4
- Book Value per Share
- 158.56
- Face Value
- 2.00
- Total Debt
- 14
- Net Working Capital
- 1,020
- Contingent Liabilities
- 4
- Book Value per Share
- 158.56
- Face Value
- 2.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 44 | 71 | 3 | -22 | 56 | 228 | 94 | 248 | 91 | -2 | |
| Cash from Investing | -35 | -46 | -15 | -242 | -100 | -298 | -202 | -165 | -459 | -25 |
| Cash from Financing | -8 | -28 | 15 | 302 | 3 | 95 | 90 | -21 | 375 | -3 |
| 1 | -2 | 3 | 38 | -42 | 25 | -18 | 62 | 8 | -30 | |
| Free Cash Flow | 26 | 58 | -20 | -51 | 30 | 201 | 36 | 183 | -44 | -97 |
| OCF / Net Profit | 1.36 | 1.05 | 0.04 | -0.43 | -0.38 | -0.60 | 0.75 | -1.50 | 0.57 | -0.02 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 44 | 219 | 197 | 399 | 405 | 279 |
| OCF / Net Profit | 1.36 | 1.05 | 0.04 | -0.43 | -0.38 | -0.60 | 0.75 | -1.50 | 0.57 | -0.02 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 44 | 219 | 197 | 399 | 405 | 279 |
Mar 2017
- 44
- Cash from Investing
- -35
- Cash from Financing
- -8
- 1
- Free Cash Flow
- 26
- OCF / Net Profit
- 1.36
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.36
- Cumulative 5-Year FCF
- 0
Mar 2018
- 71
- Cash from Investing
- -46
- Cash from Financing
- -28
- -2
- Free Cash Flow
- 58
- OCF / Net Profit
- 1.05
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.05
- Cumulative 5-Year FCF
- 0
Mar 2019
- 3
- Cash from Investing
- -15
- Cash from Financing
- 15
- 3
- Free Cash Flow
- -20
- OCF / Net Profit
- 0.04
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.04
- Cumulative 5-Year FCF
- 0
Mar 2020
- -22
- Cash from Investing
- -242
- Cash from Financing
- 302
- 38
- Free Cash Flow
- -51
- OCF / Net Profit
- -0.43
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- -0.43
- Cumulative 5-Year FCF
- 0
Mar 2021
- 56
- Cash from Investing
- -100
- Cash from Financing
- 3
- -42
- Free Cash Flow
- 30
- OCF / Net Profit
- -0.38
- Cumulative 5-Year FCF
- 44
- OCF / Net Profit
- -0.38
- Cumulative 5-Year FCF
- 44
Mar 2022
- 228
- Cash from Investing
- -298
- Cash from Financing
- 95
- 25
- Free Cash Flow
- 201
- OCF / Net Profit
- -0.60
- Cumulative 5-Year FCF
- 219
- OCF / Net Profit
- -0.60
- Cumulative 5-Year FCF
- 219
Mar 2023
- 94
- Cash from Investing
- -202
- Cash from Financing
- 90
- -18
- Free Cash Flow
- 36
- OCF / Net Profit
- 0.75
- Cumulative 5-Year FCF
- 197
- OCF / Net Profit
- 0.75
- Cumulative 5-Year FCF
- 197
Mar 2024
- 248
- Cash from Investing
- -165
- Cash from Financing
- -21
- 62
- Free Cash Flow
- 183
- OCF / Net Profit
- -1.50
- Cumulative 5-Year FCF
- 399
- OCF / Net Profit
- -1.50
- Cumulative 5-Year FCF
- 399
Mar 2025
- 91
- Cash from Investing
- -459
- Cash from Financing
- 375
- 8
- Free Cash Flow
- -44
- OCF / Net Profit
- 0.57
- Cumulative 5-Year FCF
- 405
- OCF / Net Profit
- 0.57
- Cumulative 5-Year FCF
- 405
Mar 2026
- -2
- Cash from Investing
- -25
- Cash from Financing
- -3
- -30
- Free Cash Flow
- -97
- OCF / Net Profit
- -0.02
- Cumulative 5-Year FCF
- 279
- OCF / Net Profit
- -0.02
- Cumulative 5-Year FCF
- 279
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 275.93 | 576.36 | 636.95 | 391.04 | -1117.82 | -53.37 | 8.77 | -11.56 | 10.52 | 7.29 |
| Book Value (₹) | 5948.60 | 6528.44 | 7164.46 | 5476.91 | 4358.55 | 25.94 | 21.77 | 10.06 | 150.57 | 158.56 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 |
| Cash EPS (₹) | 4.34 | 7.02 | 7.56 | 5.32 | -8.34 | -24.75 | 10.86 | -9.28 | 13.10 | 10.26 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 11.44% | 21.88% | 20.32% | 14.31% | 9.70% | -26.12% | 26.27% | -8.77% | 10.26% | 7.23% |
| Net Margin % | 5.11% | 11.33% | 10.96% | 6.90% | -17.37% | -32.85% | 9.75% | -11.46% | 12.27% | 8.28% |
| ROE % | 4.75% | 9.24% | 9.30% | 6.54% | -22.73% | -101.46% | 50.47% | -72.66% | 13.15% | 4.72% |
| ROCE % | 6.57% | 13.83% | 13.69% | 9.77% | -29.06% | -73.83% | 42.75% | -20.46% | 16.66% | 6.67% |
| 3.79% | 7.44% | 7.46% | 4.11% | -10.81% | -24.80% | 6.77% | -8.30% | 6.74% | 4.06% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 68 | 73 | 75 | 83 | 85 | 81 | 79 | 62 | 61 | 57 |
| Inventory Days | 60 | 64 | 61 | 57 | 48 | 43 | 53 | 45 | 51 | 58 |
| Payable Days | 36 | 65 | 67 | 69 | 69 | 81 | 100 | 72 | 88 | 93 |
| 92 | 72 | 68 | 71 | 63 | 43 | 33 | 36 | 24 | 23 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.08x | 0.04x | 0.06x | 0.05x | 0.04x | 0.66x | 0.47x | 1.57x | 0.00x | 0.01x |
| Interest Coverage (x) | 8.96x | 35.73x | 29.91x | 18.49x | -237.05x | -90.70x | 12.41x | -4.62x | 14.58x | 15.78x |
| 1.98x | 2.00x | 1.94x | 2.78x | 2.54x | 1.04x | 1.05x | 1.06x | 2.69x | 4.35x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 11.31% | -5.15% | 14.66% | 7.88% | 13.64% | 38.76% | 10.74% | 12.22% | -9.16% | 2.82% |
| Operating Profit Growth % | -16.52% | 80.33% | 6.17% | -24.02% | -22.98% | -473.76% | 211.36% | -109.63% | 907.36% | -19.90% |
| Net Profit Growth % | -26.26% | 108.88% | 10.51% | -32.05% | -385.95% | -162.52% | 132.85% | -231.91% | 197.31% | -30.66% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -231.91% | 190.93% | -30.66% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 45.13x | 63.92x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 3.15x | 2.94x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.64% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -5.58x | 26.32x | 30.31x |
Mar 2017
- EPS (₹)
- 275.93
- Book Value (₹)
- 5948.60
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 4.34
- Operating Margin %
- 11.44%
- Net Margin %
- 5.11%
- ROE %
- 4.75%
- ROCE %
- 6.57%
- 3.79%
- Debtor Days
- 68
- Inventory Days
- 60
- Payable Days
- 36
- 92
- Debt to Equity (x)
- 0.08x
- Interest Coverage (x)
- 8.96x
- 1.98x
- Revenue Growth %
- 11.31%
- Operating Profit Growth %
- -16.52%
- Net Profit Growth %
- -26.26%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 576.36
- Book Value (₹)
- 6528.44
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.02
- Operating Margin %
- 21.88%
- Net Margin %
- 11.33%
- ROE %
- 9.24%
- ROCE %
- 13.83%
- 7.44%
- Debtor Days
- 73
- Inventory Days
- 64
- Payable Days
- 65
- 72
- Debt to Equity (x)
- 0.04x
- Interest Coverage (x)
- 35.73x
- 2.00x
- Revenue Growth %
- -5.15%
- Operating Profit Growth %
- 80.33%
- Net Profit Growth %
- 108.88%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 636.95
- Book Value (₹)
- 7164.46
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 7.56
- Operating Margin %
- 20.32%
- Net Margin %
- 10.96%
- ROE %
- 9.30%
- ROCE %
- 13.69%
- 7.46%
- Debtor Days
- 75
- Inventory Days
- 61
- Payable Days
- 67
- 68
- Debt to Equity (x)
- 0.06x
- Interest Coverage (x)
- 29.91x
- 1.94x
- Revenue Growth %
- 14.66%
- Operating Profit Growth %
- 6.17%
- Net Profit Growth %
- 10.51%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 391.04
- Book Value (₹)
- 5476.91
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 5.32
- Operating Margin %
- 14.31%
- Net Margin %
- 6.90%
- ROE %
- 6.54%
- ROCE %
- 9.77%
- 4.11%
- Debtor Days
- 83
- Inventory Days
- 57
- Payable Days
- 69
- 71
- Debt to Equity (x)
- 0.05x
- Interest Coverage (x)
- 18.49x
- 2.78x
- Revenue Growth %
- 7.88%
- Operating Profit Growth %
- -24.02%
- Net Profit Growth %
- -32.05%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- -1117.82
- Book Value (₹)
- 4358.55
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -8.34
- Operating Margin %
- 9.70%
- Net Margin %
- -17.37%
- ROE %
- -22.73%
- ROCE %
- -29.06%
- -10.81%
- Debtor Days
- 85
- Inventory Days
- 48
- Payable Days
- 69
- 63
- Debt to Equity (x)
- 0.04x
- Interest Coverage (x)
- -237.05x
- 2.54x
- Revenue Growth %
- 13.64%
- Operating Profit Growth %
- -22.98%
- Net Profit Growth %
- -385.95%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- -53.37
- Book Value (₹)
- 25.94
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -24.75
- Operating Margin %
- -26.12%
- Net Margin %
- -32.85%
- ROE %
- -101.46%
- ROCE %
- -73.83%
- -24.80%
- Debtor Days
- 81
- Inventory Days
- 43
- Payable Days
- 81
- 43
- Debt to Equity (x)
- 0.66x
- Interest Coverage (x)
- -90.70x
- 1.04x
- Revenue Growth %
- 38.76%
- Operating Profit Growth %
- -473.76%
- Net Profit Growth %
- -162.52%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 8.77
- Book Value (₹)
- 21.77
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 10.86
- Operating Margin %
- 26.27%
- Net Margin %
- 9.75%
- ROE %
- 50.47%
- ROCE %
- 42.75%
- 6.77%
- Debtor Days
- 79
- Inventory Days
- 53
- Payable Days
- 100
- 33
- Debt to Equity (x)
- 0.47x
- Interest Coverage (x)
- 12.41x
- 1.05x
- Revenue Growth %
- 10.74%
- Operating Profit Growth %
- 211.36%
- Net Profit Growth %
- 132.85%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -11.56
- Book Value (₹)
- 10.06
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -9.28
- Operating Margin %
- -8.77%
- Net Margin %
- -11.46%
- ROE %
- -72.66%
- ROCE %
- -20.46%
- -8.30%
- Debtor Days
- 62
- Inventory Days
- 45
- Payable Days
- 72
- 36
- Debt to Equity (x)
- 1.57x
- Interest Coverage (x)
- -4.62x
- 1.06x
- Revenue Growth %
- 12.22%
- Operating Profit Growth %
- -109.63%
- Net Profit Growth %
- -231.91%
- -231.91%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- -5.58x
Mar 2025
- EPS (₹)
- 10.52
- Book Value (₹)
- 150.57
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 13.10
- Operating Margin %
- 10.26%
- Net Margin %
- 12.27%
- ROE %
- 13.15%
- ROCE %
- 16.66%
- 6.74%
- Debtor Days
- 61
- Inventory Days
- 51
- Payable Days
- 88
- 24
- Debt to Equity (x)
- 0.00x
- Interest Coverage (x)
- 14.58x
- 2.69x
- Revenue Growth %
- -9.16%
- Operating Profit Growth %
- 907.36%
- Net Profit Growth %
- 197.31%
- 190.93%
- P/E (x)
- 45.13x
- P/B (x)
- 3.15x
- Dividend Yield %
- 0.00%
- 26.32x
Mar 2026
- EPS (₹)
- 7.29
- Book Value (₹)
- 158.56
- Dividend per Share (₹)
- 3.00
- Cash EPS (₹)
- 10.26
- Operating Margin %
- 7.23%
- Net Margin %
- 8.28%
- ROE %
- 4.72%
- ROCE %
- 6.67%
- 4.06%
- Debtor Days
- 57
- Inventory Days
- 58
- Payable Days
- 93
- 23
- Debt to Equity (x)
- 0.01x
- Interest Coverage (x)
- 15.78x
- 4.35x
- Revenue Growth %
- 2.82%
- Operating Profit Growth %
- -19.90%
- Net Profit Growth %
- -30.66%
- -30.66%
- P/E (x)
- 63.92x
- P/B (x)
- 2.94x
- Dividend Yield %
- 0.64%
- 30.31x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-13 - Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Schedule of meet
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-13 - Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Transcript
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026
Feb 2026